FindTrial
Sign In

Tele-spirometry in Primary Care-Randomized Clinical Trial Cluster:Telemedicine in Chronic Obstructive Pulmonary Disease

Tele-spirometry in Primary Care - Randomized Clinical Trial Cluster: the Effectiveness of Multifaceted Intervention in Symptoms Patients With Respiratory Illness

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02901535
Acronym
RESPIRANET-C
Enrollment
240
Registered
2016-09-15
Start date
2015-04-30
Completion date
2017-12-31
Last updated
2017-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Keywords

telemedicine, chronic obstructive pulmonary disease, Primary Health care, spirometry

Brief summary

The purpose of this study is to determine the effectiveness of telemedicine multifaceted intervention in symptoms patients with chronic obstructive pulmonary disease.

Detailed description

This study is a randomized clinical trial for patients with chronic obstructive pulmonary disease from a primary care. The purpose is to determine the effectiveness of telemedicine (teleconsultation and telemonitoring) in control of chronic obstructive pulmonary disease symptoms.

Interventions

OTHERSpirometry

Spirometry in baseline

OTHERtelemonitoring

telemonitoring (phone call nurse - 45 and 90 days)

OTHERteleconsultation

teleconsultation (general practioner received phone call to respiratory care)

OTHERSpirometry - 20 weeks

Spirometry (20 weeks)

Sponsors

Federal University of Rio Grande do Sul
CollaboratorOTHER
Conselho Nacional de Desenvolvimento Científico e Tecnológico
CollaboratorOTHER_GOV
Ministry of Health, Brazil
CollaboratorOTHER_GOV
Hospital de Clinicas de Porto Alegre
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
12 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* spirometry from TelessaudeRS-Universidade Federal do Rio Grande do Sul (from randomization cluster), Modified Medical Research Council Dyspnea \> 0

Exclusion criteria

* normal or restrictive spirometry, low quality spirometries (inadequate)

Design outcomes

Primary

MeasureTime frameDescription
Symptoms20 a 22 weeksModified Medical Research Council Dyspnea Scale (difference in mMRC)

Secondary

MeasureTime frameDescription
Spirometry - FEV120 a 22 weeksspirometry parameters - FEV 1 (forced expiratory volume in one second)
Spirometry - FVC20 a 22 weeksspirometry parameters - FVC (forced vital capacity)

Countries

Brazil

Contacts

Primary ContactMarcelo R. Gonçalves, PhD
marcelorog@gmail.com5191175156
Backup ContactCynthia G Molina-Bastos, MD
cyncarol@gmail.com5191322585

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026